3-4-5 Rule Dr. Jack Cush reviews more than a dozen news, journal articles and RNL highlights from this past week on https://t.co/V10S4oVFsv https://t.co/4iQERIh5Zl https://t.co/bwSk9L7ucC

⚠️Beware not all bone marrow oedema =#AxSpA on MRI ! Signal seen in 17% volunteers at SIJs @DrPoddubnyy #RNL2023 https://t.co/xTKuSRXK72 https://t.co/c09QjSkJBP

FRAX Tool is Suboptimal in Predicting Osteoporosis Fracture Risk in Younger Post-menopausal Women https://t.co/8tc51AJ14n https://t.co/lhF7iwl0N3

With all the new adalimumab biosimilars happening in 2023, where's the pen? Now the FDA has approved an ADA biosimilar, Cyltezo, Autoinjector Pen! https://t.co/TgsA46xGsv https://t.co/rXcRcp7tDX

Dennis Poddubnyy #RNL2023 MRI sequences for axSpA: Semi-coronal- T1 weighted, T2 STIR, T1 weighted w fat suppression Semi-axial- T2 STIR @RheumNow https://t.co/aidLu7GcQH https://t.co/YOrboYl6pW

Watch: GPA Treatment Choices https://t.co/9v6C5nOLqu https://t.co/1E347ulsvR

Colchicine does not work in Hand OA. Danish trial of 100 HOA pts (age 71 yrs) given placebo or COL 0.5 mg bid x 12wk. Finger pain improved –13·9 mm w/ colchicine vs –13·5 mm w/ PBO (NS). More adverse events w/ Colchicine (72% vs 44%) https://t.co/042BQcAFWf https://t.co/EldLmjVisD

Dr. Deodhar reminds us of his "3,4,5 rule" for diagnosing AS. *Erosions in 3 or more SIJ quadrants *BME in 4 or more SIJ quadrants *Fat lesions in 5 of more SIJ quadrants #RNL2023 @RheumNow https://t.co/T9iWLcNL8b https://t.co/BskCNz9Klj

Peresolimab's Potential in Rheumatoid Arthritis Peresolimab is a humanized IgG1 monoclonal antibody that acts as a PD-1 agonist (stimulator). The NEJM reports that PER met its efficacy primary endpont in treating patients with active RA. https://t.co/tBAC2vO31f https://t.co/pAknsSnnNT

U.S. FDA Approves RINVOQ® (upadacitinib) as a Once-Daily Pill for Moderately to Severely Active Crohn's Disease in Adults based on induction studies, U-EXCEED, U-EXCEL,& U-ENDURE maintenance study. This is 7th FDA approval for RINVOQ https://t.co/JFyiETe43S https://t.co/zGJKZ3l0d4

Join us for the final Tuesday Night Rheumatology of May. This webinar will feature highlights from these lectures followed by live audience Q & A: Methotrexate Use: 50 Yr. Perspective Myths vs Reality in RA Biosimilars - Back on the Agenda https://t.co/cqFNCRlGym https://t.co/fNS6cGBuDB

Save the date! We'll be tuning in live from Milan for EULAR '23. Count on us for: -KOL perspective videos -Clinical Trial Highlights -Daily Faculty Recaps -Live Streaming and more! https://t.co/uR4ZwnPGiF